Cite
HARVARD Citation
Caiazza, F. et al. (2016). Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells. Endocrine-related cancer. 23 (4), pp. 323-334. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Caiazza, F. et al. (2016). Preclinical evaluation of the AR inhibitor enzalutamide in triple-negative breast cancer cells. Endocrine-related cancer. 23 (4), pp. 323-334. [Online].